Opaleye Management Inc. Q4 2016 Filing
Filed February 21, 2017
Portfolio Value
$169.7M
Holdings
40
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | 2L9BLUEPRINT MEDICINES | 880,000 | $24.7M | 14.54% | |
| 2 | AXGNAXOGEN INC | 1,970,000 | $17.7M | 10.45% | |
| 3 | —ARIAD PHARMACEUTICALS INC | 1,000,000 | $12.4M | 7.33% | |
| 4 | —AEVI GENOMIC MEDICINE INC | 1,500,000 | $7.8M | 4.58% | |
| 5 | FGENEURFIBROGEN INC | 330,000 | $7.1M | 4.16% | |
| 6 | —FOAMIX PHARMACEUTICALS LTD | 495,000 | $5.5M | 3.24% | |
| 7 | AGIOAGIOS PHARMACEUTICALS | 130,000 | $5.4M | 3.20% | |
| 8 | CMRXEURCHIMERIX INC | 1,170,000 | $5.4M | 3.17% | |
| 9 | CDXSCODEXIS INC | 1,170,000 | $5.4M | 3.17% | |
| 10 | —AQUINOX PHARMACEUTICALS INC | 310,000 | $5.1M | 3.02% | |
| 11 | TBPHTHERAVANCE BIOPHARMA INC | 158,200 | $5.0M | 2.97% | |
| 12 | —MOMENTA PHARMACEUTICALS INC | 330,000 | $5.0M | 2.93% | |
| 13 | —ADAMAS PHARMACEUTICALS INC | 285,000 | $4.8M | 2.84% | |
| 14 | CARAEURCARA THERAPEUTICS | 475,000 | $4.4M | 2.60% | |
| 15 | PRTAPROTHENA CORP PLC | 82,500 | $4.1M | 2.39% | |
| 16 | —LOXO ONCOLOGY | 125,000 | $4.0M | 2.37% | |
| 17 | EGRXEAGLE PHARMACEUTICALS INC | 50,000 | $4.0M | 2.34% | |
| 18 | —EDGE THERAPEUTICS INC | 280,000 | $3.5M | 2.06% | |
| 19 | MGNXMACROGENICS INC | 170,000 | $3.5M | 2.05% | |
| 20 | XENEXENON PHARMACEUTICALS INC | 405,000 | $3.1M | 1.84% | |
| 21 | ENTAENANTA PHARMACEUTICALS INC | 90,000 | $3.0M | 1.78% | |
| 22 | —STRONGBRIDGE BIOPHARMA PLC | 1,160,000 | $2.8M | 1.64% | |
| 23 | OMEROMEROS CORP | 265,300 | $2.6M | 1.55% | |
| 24 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 270,000 | $2.4M | 1.42% | |
| 25 | —LION BIOTECHNOLOGIES INC | 300,000 | $2.1M | 1.23% | |
| 26 | —ABEONA THERAPEUTICS INC | 400,000 | $1.9M | 1.14% | |
| 27 | CTMXCYTOMX THERAPEUTICS INC | 170,000 | $1.9M | 1.10% | |
| 28 | —PROTEOSTASIS THERAPEUTICS INC | 150,000 | $1.8M | 1.08% | |
| 29 | —IMPRIMIS PHARMACEUTICALS INC | 720,000 | $1.8M | 1.06% | |
| 30 | SG7SAGE THERAPEUTICS INC | 35,000 | $1.8M | 1.05% | |
| 31 | —NEURODERM LTD | 115,000 | $1.7M | 1.02% | |
| 32 | —WAFERGEN BIO-SYSTEMS INC | 320,000 | $1.6M | 0.93% | |
| 33 | —CORIUM INTERNATIONAL INC | 380,000 | $1.5M | 0.91% | |
| 34 | GBYSANGAMO BIOSCIENCES INC | 400,000 | $1.2M | 0.72% | |
| 35 | —ACHAOGEN INC | 80,000 | $1.0M | 0.61% | |
| 36 | —PROTALIX BIOTHERAPEUTICS INC | 1,930,000 | $859K | 0.51% | |
| 37 | OCULOCULAR THERAPEUTIX INC | 93,600 | $783K | 0.46% | |
| 38 | TREURTRILLIUM THERAPEUTICS INC | 110,000 | $622K | 0.37% | |
| 39 | —BIOLINERX LTD | 250,000 | $230K | 0.14% | |
| 40 | —AGILE THERAPEUTICS INC | 15,000 | $85K | 0.05% |